Patient knows best: Blinded assessment of nonadherence with antituberculous therapy by physicians, nurses, and patients compared with urine drug levels

Preventive Medicine

Volumn 40, Issue 1, 2005, Pages 41-45

  MacIntyre, C R ^a,d   Goebel, K ^b   Brown, G V ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Victoria ^*  (Australia)

^c VICTORIA UNIVERSITY   (Australia)

^d NATIONAL CENTRE FOR IMMUNISATION RESEARCH AND SURVEILLANCE   (Australia)

Author keywords

Isoniazid; Nonadherence; Patient self report; Tuberculosis

Indexed keywords

ISONIAZID; TUBERCULOSTATIC AGENT;

ACCURACY; ADULT; ARTICLE; AUSTRALIA; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG URINE LEVEL; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NURSE; PHYSICIAN; PILL; PRIORITY JOURNAL; SELF REPORT; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; NURSES; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; PHYSICIANS; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; VICTORIA;

EID: 7644243023     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ypmed.2004.04.045     Document Type: Article

References (21)

1. Sbarbaro J.A. Strategies to improve compliance with therapy. Am. J. Med. 79:1985;34-37
2. Pulido Ortega F., Sanchez de Rivera J.M., Rubio Garcia R., et al. Predictive factors of non-compliance with anti-tuberculosis treatment in patients infected with the human immunodeficiency virus. Rev. Clin. Esp. 197:1997;163-166
3. Sbarbaro J.A., Steiner J.F. Noncompliance with medications: vintage wine in new (pill) bottles. Ann. Allergy. 66:1991;273-275
4. Sbarbaro J.A. The patient-physician relationship: compliance revisited. Ann. Allergy. 64:1990;325-331
5. MacIntyre C.R., Goebel K., Brown G.V., Skull S.A., Starr M., Fulinfaw R.O. A randomised, controlled clinical trial of the efficacy of family based direct observation of anti-tuberculous therapy in an urban, developed-country setting. Int. J. Tuberc. Lung Dis. 7(9):2003;848-854
6. Starr M., Sawyer S., Carlin J., Powell C., Newman R., Johnson P. A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence. J. Paediatr. Child Health. 35:1999;350-354
7. Dean AG, Dean JA, Coulombier D, et al. Epi Info Version 6. Atlanta, (GA):Centers for Disease Control, 1994.
8. Iskedjian M., Einarson T.R., MacKeigan L.D., et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin. Ther. 24:2002;302-316
9. Gordin F., Chaisson R.E., Matts J.P., et al. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American Health Organization, and the Centers for Disease Control and Prevention Study Group Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. JAMA. 283:2000;1445-1450
10. Chaulk C.P., Kazandjian V.A. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the public health tuberculosis guidelines panel. JAMA. 279:1998;943-948
11. Agrawal S., Kaur K.J., Singh I., Bhade S.R., Kaul C.L., Panchagnula R. Assessment of bioequivalence of rifampicin, isoniazid and pyrazinamide in a four drug fixed dose combination with separate formulations at the same dose levels. Int. J. Pharm. 233:2002;169-177
12. Padgaonkar K.A., Revankar S.N., Bhatt A.D., et al. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers. Int. J. Tuberc. Lung Dis. 3:1999;627-631
13. Rey E., Gendrel D., Treluyer J.M., et al. Isoniazid pharmacokinetics in children according to acetylator phenotype. Fundam. Clin. Pharmacol. 15:2001;355-359
14. Descamps D., Flandre P., Calvez V., et al. Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilege (Agence Nationale de Recherches sur le SIDA 072 Study Team). JAMA. 283:2000;205-211
15. Markowitz M. Resistance, fitness, adherence, and potency: mapping the paths to virologic failure. JAMA. 283:2000;250-251
16. McHutchison J.G., Manns M., Patel K., et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology. 123:2002;1061-1069
17. Schectman J.M., Nadkarni M.M., Voss J.D. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 25:2002;1015-1021
18. Burkhart P.V., Dunbar-Jacob J.M., Fireman P., Rohay J. Children's adherence to recommended asthma self-management. Pediatr. Nursing. 28:2002;409-414
19. van Rossum A.M., Bergshoeff A.S., Fraaij P.L., et al. Therapeutic drug monitoring of indinavir and nelfinavir to assess adherence to therapy in human immunodeficiency virus-infected children. Pediatr. Infect. Dis. J. 21:2002;743-747
20. Jackevicius C.A., Mamdani M., Tu J.V. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 288:2002;462-467
21. Maidment R., Livingston G., Katona C. Just keep taking the tablets: adherence to antidepressant treatment in older people in primary care. Int. J. Geriatr. Psychiatry. 17:2002;752-757